Burlingame, Feb. 23, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global acne medication market is estimated to be valued at US$ 7,594.3 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Acne Medication Market:
Major players operating in the market are focusing on adopting strategies such as acquisitions, which is expected to drive the market growth over the forecast period. For instance, in January 2022, STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it had entered into a definitive agreement to acquire assets related to Theravant Corporation’s TheraClear System. Theravant Corporation develops, produces, markets and sells high quality, affordable products for the medical aesthetic marketplace. The company develops and markets a novel, U.S. FDA-cleared, system for the in-office treatment of many common forms of acne. This acquisition will enable STRATA Skin Sciences, Inc.’s expansion into the acne treatment market.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5182
Acne Medication Market Report Coverage
| Report Coverage | Details | ||
| Base Year: | 2021 | Market Size in 2022: | US$ 7,594.3 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 4.5% | 2030 Value Projection: | US$ 10,839.8 Mn |
| Geographies covered: |
| ||
| Segments covered: |
| ||
| Companies covered: | Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Key Market Takeaways:
The global acne medication market is expected to exhibit a CAGR of 4.5% during the forecast period due to increasing adoption of unhealthy lifestyle by teenagers. For instance, according to the American Journal of Clinical Dermatology in August 2020, the development of acne in some populations such as the Canadian Inuit, South African Zulus, and others after the adoption of a Western diet suggests that the latter plays a role in acne. Acne has been linked to these people's embrace of Western diets, which include processed foods, dairy, and refined sugars. Additionally, acne is brought on by unhealthy lifestyle choices such as smoking, drinking, eating erratically, and sleeping irregularly.
Among drug class, fixed dose combinations segment is expected to hold a dominant position over the forecast period, owing to increasing approvals of fixed dose combinations by the regulatory bodies to the key players. For instance, in June 2022, Zydus Lifesciences Limited, a multinational pharmaceutical company, received approval from the U.S. Food and Drug Administration to market adapalene and benzoyl peroxide topical gel, 0.3%/2.5%. A combination of adapalene (a retinoid) and benzoyl peroxide (an antibiotic and skin peeling agent) is used to decrease the number and severity of acne pimples.
On the basis of type, prescription segment is expected to hold a dominant position over the forecast period, owing to increasing product launches of prescription acne medications. For instance, in April 2021, Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd. in the U. S., announced the launch of generic Absorica (isotretinoin) capsules in strengths of 10 mg, 20 mg, 25 mg, 30 mg, 35 mg, and 40 mg for the treatment of severe recalcitrant nodular acne in non-pregnant patients of 12 years of age and older who have multiple inflammatory nodules with a diameter of 5 mm or more.
Competitive Landscape:
Key players operating in the global acne medication market include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/5182
Market Segmentation:
- Global Acne Medication Market, By Drug Class:
- Topical Retinoid
- Oral Retinoid
- Topical Antibiotics
- Oral Antibiotics
- Clindamycin + Benzoyl Peroxide
- Clindamycin + Tretinoin
- Adapalene + Benzoyl Peroxide
- Tretinoin + Benzoyl Peroxide
- Others
- Retinoid
- Antibiotics
- Fixed Dose Combinations
- Salicylic Acid
- Azelaic Acid
- Benzoyl Peroxide
- Others
- Global Acne Medication Market, By Type:
- Prescription
- OTC
- Global Acne Medication Market, By Indication:
- Inflammatory Acne
- Non-Inflammatory Acne
- Global Acne Medication Market, By Formulation:
- Topical Medication
- Oral Medication
- Global Acne Medication Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Acne Medication Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
- North America
Related Market Intelligence Reports:
Dermatomyositis Market, by Type (Adult Dermatomyositis, Dermatomyositis Sine Myositis, and Juvenile (Childhood) Dermatomyositis (JDMS)), by Treatment Type (Anti-inflammatory Medication, Immunosuppressive Drugs, Immunoglobulin, and Others (Plasma Exchange, Monoclonal antibody among others)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
Dermatological Therapeutic Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Vitiligo, Hidradenitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Calcineurin Inhibitors, Retinoids, and Other Drug Classes), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
